ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy
- PMID: 26869655
- PMCID: PMC5702789
- DOI: 10.1200/JOP.2015.004812
ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy
Abstract
Purpose: Hospital readmissions are often cited as a marker of poor quality of care. Limited data suggest some readmissions may be preventable depending upon definitions and available outpatient support.
Methods: General criteria to define preventable and not preventable admissions were developed before data collection began. The records of sequential nonsurgical oncology readmissions were reviewed independently by two reviewers. When the reviewers disagreed about assigning admissions as preventable or not preventable, a third reviewer was the tie breaker. The reasons for assigning admissions as preventable or not preventable were analyzed.
Results: Seventy-two readmissions occurring among 69 patients were analyzed. The first two reviewers agreed that 18 (25%) of 72 were preventable and that 29 (40%) of 72 were not. A third reviewer found four of the split 25 cases to be preventable; therefore, the consensus preventability rate was 22 (31%) of 72. The most common causes of preventability were overwhelming symptoms in patients who qualified for hospice but were not participating in hospice and insufficient communication between patients and the care team about symptom burden. The most common reason for assignment of a not preventable admission was a high symptom burden among patients without strong indications for hospice or for whom aggressive outpatient management was inadequate. The median survival after readmission was 72 days.
Conclusion: A substantial proportion of oncology readmissions could be prevented with better anticipation of symptoms in high-risk ambulatory patients and enhanced communication about symptom burden between patients and physicians before an escalation that leads to an emergency department visit. Managing symptoms in patients who are appropriate for hospice is challenging. Readmission is a marker of poor prognosis.
Copyright © 2016 by American Society of Clinical Oncology.
Figures
Comment in
-
Benefits and Pitfalls of Using Administrative Data to Study Hospitalization Patterns in Patients With Cancer Treated With Chemotherapy.J Oncol Pract. 2016 Feb;12(2):140-1. doi: 10.1200/JOP.2015.008482. J Oncol Pract. 2016. PMID: 26869654 No abstract available.
Similar articles
-
Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions.J Gen Intern Med. 1996 Oct;11(10):597-607. doi: 10.1007/BF02599027. J Gen Intern Med. 1996. PMID: 8945691
-
Are Readmissions After THA Preventable?Clin Orthop Relat Res. 2017 May;475(5):1414-1423. doi: 10.1007/s11999-016-5156-x. Epub 2016 Nov 11. Clin Orthop Relat Res. 2017. PMID: 27837400 Free PMC article.
-
30-day-or-sooner readmissions of gastrointestinal medical oncology patients following cancer center inpatient service discharge: characteristics and preventability.Hosp Pract (1995). 2014 Dec;42(5):34-44. doi: 10.3810/hp.2014.12.1157. Hosp Pract (1995). 2014. PMID: 25485916
-
Physician consensus on preventability and predictability of readmissions based on standard case scenarios.Neth J Med. 2016 Dec;74(10):434-442. Neth J Med. 2016. PMID: 27966437
-
Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review.J Am Geriatr Soc. 2018 Mar;66(3):602-608. doi: 10.1111/jgs.15244. Epub 2018 Feb 22. J Am Geriatr Soc. 2018. PMID: 29468640
Cited by
-
Estimating the Time Toxicity of Contemporary Systemic Treatment Regimens for Advanced Esophageal and Gastric Cancers.Cancers (Basel). 2023 Nov 30;15(23):5677. doi: 10.3390/cancers15235677. Cancers (Basel). 2023. PMID: 38067380 Free PMC article.
-
Emerging burden of post-cancer therapy complications on unplanned hospitalisation and costs among Australian cancer patients: a retrospective cohort study over 14 years.Sci Rep. 2025 Feb 8;15(1):4709. doi: 10.1038/s41598-025-89247-y. Sci Rep. 2025. PMID: 39922897 Free PMC article.
-
Management and survival analysis of elderly patients with a cancer in the digestive system who refused to receive anticancer treatments.Support Care Cancer. 2018 Jul;26(7):2333-2339. doi: 10.1007/s00520-018-4065-9. Epub 2018 Feb 7. Support Care Cancer. 2018. PMID: 29417291 Free PMC article.
-
Potentially avoidable hospitalizations after chemotherapy: Differences across medicare and the Veterans Health Administration.Cancer. 2020 Jul 15;126(14):3297-3302. doi: 10.1002/cncr.32896. Epub 2020 May 13. Cancer. 2020. PMID: 32401340 Free PMC article.
-
Performance of electronic medical record tool in predicting 6-month mortality in hospitalized patients with cancer.J Hosp Med. 2025 Aug;20(8):829-836. doi: 10.1002/jhm.70012. Epub 2025 Feb 17. J Hosp Med. 2025. PMID: 39961789 Free PMC article.
References
-
- American Cancer Society : Cancer Facts and Figures 2012 http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/docume...
-
- DeSantis CE Lin CC Mariotto AB, etal: Cancer treatment and survivorship statistics, 2014 CA Cancer J Clin 64:252–271,2014 - PubMed
-
- Murphy SL, Xu J, Kochanek KD: Deaths: Final data for 2010 Natl Vital Stat Rep 61:1–117,2013 - PubMed
-
- Peppercorn JM Smith TJ Helft PR, etalAmerican Society of Clinical Oncology : American society of clinical oncology statement: Toward individualized care for patients with advanced cancer J Clin Oncol 29:755–760,2011 - PubMed
-
- McIllmurray M: Hanks G, Cherny NI, Christakis NA, et al.The medical treatment of cancer in palliative care, Oxford Textbook of Palliative Medicine 513–525,2010. Oxford: Oxford University Press
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous